Stock data
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC) reported net income of -US$45.55M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-06-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | — | — | -US$51.19M | -US$45.55M | — |
| 2025 | — | — | -US$41.77M | -US$37.92M | — |
| 2024 | — | — | -US$22.49M | -US$21.75M | — |
| 2023 | — | — | -US$19.08M | -US$19.56M | — |
| 2022 | — | — | -US$17.85M | -US$18.21M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$12.81M | — |
| 2026-03-31 | US$0.00M | -US$11.94M | — |
| 2025-12-31 | US$0.00M | -US$11.84M | — |
| 2025-09-30 | US$0.00M | -US$8.96M | — |
| 2025-06-30 | — | -US$8.80M | — |
| 2025-03-31 | US$0.00M | -US$14.50M | — |
| 2024-12-31 | US$0.00M | -US$9.55M | — |
| 2024-09-30 | US$0.00M | -US$5.06M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.